You are here: Home
 
Banner
Regional variations in US cancer imaging data: a warning for imaging overuse

Regional variations in US cancer imaging data: a warning for imaging overuse

Danil V Makarov speaks to Gemma Westcott, Commissioning Editor: Danil V Makarov is an Assistant Professor and Director of Surgical Research in the Department o...

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

Phase I data regarding the experimental cancer agent ONT-380 were presented recently at the 2015 San Antonio Breast Cancer Symposium, indicating initial effi...

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

In this interview, Pat Whitworth, MD, Breast Surgical Oncologist and Director of the Nashville Breast Center in Tennessee (USA), discusses recent advances in...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
Save
Cancel
Reset

News

Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and Chief Executive Officer, at the Bernstein 32nd Annual Strategic

Thursday, 26 May 2016 Comments

Press Releases

U.S. FDA Approves CSL Behring's AFSTYL for adults and children with haemophilia

CSL announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® , CSL Behring’s novel long-lasting recombinant factor VIII single-chain therapy for adults and children with haemophilia

Thursday, 26 May 2016 Comments

Research Insight

Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear

Allergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary and secondary efficacy endpoints. With these new results, a premarket

Monday, 16 May 2016 Comments

Techno Trends

McKesson Launches NEW Drug Spend Intelligence

McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that provides the information needed to identify

Tuesday, 1 March 2016 Comments

Industry Reports

Thunderbolt Pharma, Inc , Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma

Baxalta Incorporated , Velocity Pharmaceutical Development, LLC and Astellas Pharma Inc announced that Thunderbolt, Inc., a company established by Vitesse Biologics, acquired all rights to the Astellas BAFF/APRIL dual antagonist

Wednesday, 25 May 2016 Comments

Articles

Gastroesophageal Reflux Disease (GERD or

Gastroesophageal Reflux Disease is a condition resulting from stomach acid moving backward from the stomach into the esophagus (the tube that connects the mouth to the stomach). The acid causes

Tuesday, 9 February 2016 Comments

Banner